CD4 and COVID-19: Loyal et al. reported that the fusion peptide domain of spike protein (S816–830) was a universal immunodominant epitope for CD4+ T cells and recognized by CD4+ T cells in 20% of UHDs, 50–60% of COVID-19 convalescents, and 97% of mRNA vaccinated subjects [67].